Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|January 22, 2014
Anti-interferon beta antibody titers strongly correlate between two bioassays and in vivo biomarker expression, and indicates that a titer of 150 TRU/mL is a biologically functional cut-pointChristina Hermanrud, Malin Lundkvist Ryner, Elin Engdahl, et al.Immunogenetics|July 29, 2009
MHC class II polymorphism is associated with a canine SLE-related disease complexMaria Wilbe, Päivi Jokinen, Christina Hermanrud, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|May 14, 2014
Interferon beta treatment of multiple sclerosis increases serum interleukin-7Wangko Lundström, Christina Hermanrud, Maria Sjöstrand, et al.Plos One|March 11, 2014
Human leukocyte antigen genes and interferon beta preparations influence risk of developing neutralizing anti-drug antibodies in multiple sclerosisJenny Link, Malin Lundkvist Ryner, Katharina Fink, et al.Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|March 9, 2019
Different Interferon Beta Preparations Induce the Same Qualitative Immune Response in Human SkinChristina Hermanrud, Toni M M van Capel, Michael Auer, et al.Frontiers in Immunology|August 15, 2020
Drug Tolerant Anti-drug Antibody Assay for Infliximab Treatment in Clinical Practice Identifies Positive Cases EarlierNastya Kharlamova, Christina Hermanrud, Nicky Dunn, et al.Journal of Immunological Methods|January 19, 2016
Development and validation of cell-based luciferase reporter gene assays for measuring neutralizing anti-drug antibodies against interferon betaChristina Hermanrud, Malin Ryner, Thomas Luft, et al.Frontiers in Neurology|July 22, 2017
Development and Validation of an Enzyme-Linked Immunosorbent Assay for the Detection of Binding Anti-Drug Antibodies against Interferon BetaKathleen Ingenhoven, Daniel Kramer, Poul Erik Jensen, et al.Journal of Neuroimmunology|July 19, 2022
Longitudinal analysis of anti-drug antibody development in multiple sclerosis patients treated with interferon beta-1a (Rebif™) using B cell receptor repertoire analysisLinda van der Weele, Sabrina Pollastro, Barbera D C van Schaik, et al.BMC Medicine|November 4, 2020
Treatment- and population-specific genetic risk factors for anti-drug antibodies against interferon-beta: a GWASTill F M Andlauer, Jenny Link, Dorothea Martin, et al.Pageof 2